What’s Next? Five Things To Look Out For In August

Q2 Results Dominate August Landscape

 
• By Dean Rudge

Second-quarter earnings results from two of the Big Three – Teva and Mylan – hold much of the intrigue in August, while more competition in the nascent Avastin biosimilar market could materialize in Europe.

Whats_Next_2020_2
Financial results dominate the landscape in August • Source: Shutterstock

More from Earnings

More from Business